SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-23-023124
Filing Date
2023-08-10
Accepted
2023-08-10 17:00:46
Documents
58
Period of Report
2023-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q acrx20230630_10q.htm   iXBRL 10-Q 1647863
2 EXHIBIT 31.1 ex_552809.htm EX-31.1 7866
3 EXHIBIT 31.2 ex_552810.htm EX-31.2 7657
4 EXHIBIT 32.1 ex_552811.htm EX-32.1 6931
  Complete submission text file 0001437749-23-023124.txt   7179710

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA acrx-20230630.xsd EX-101.SCH 54192
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE acrx-20230630_cal.xml EX-101.CAL 64140
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE acrx-20230630_def.xml EX-101.DEF 392912
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE acrx-20230630_lab.xml EX-101.LAB 373019
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE acrx-20230630_pre.xml EX-101.PRE 415754
52 EXTRACTED XBRL INSTANCE DOCUMENT acrx20230630_10q_htm.xml XML 1207977
Mailing Address 25821 INDUSTRIAL BOULEVARD SUITE 400 HAYWARD CA 94545
Business Address 25821 INDUSTRIAL BOULEVARD SUITE 400 HAYWARD CA 94545 650-216-3500
ACELRX PHARMACEUTICALS INC (Filer) CIK: 0001427925 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35068 | Film No.: 231160476
SIC: 2834 Pharmaceutical Preparations